24 Jul, EOD - Indian

SENSEX 80148.88 (-0.35)

Nifty 50 24413.5 (-0.27)

Nifty Bank 51317 (-0.89)

Nifty IT 40115.05 (0.18)

Nifty Midcap 100 56872.75 (1.04)

Nifty Next 50 71844.65 (0.30)

Nifty Pharma 20908.5 (0.74)

Nifty Smallcap 100 18723.5 (1.76)

24 Jul, EOD - Global

NIKKEI 225 39154.85 (-1.11)

HANG SENG 17311.05 (-0.91)

DOW JONES 39952.92 (-1.00)

S&P 5438.37 (-2.11)

Login/Signup

Saregama India Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 532163 | NSE Symbol : SAREGAMA | ISIN : INE979A01025 | Industry : Entertainment |


Board Meeting
Announcement Date Date Of Meeting Purpose
16-May-2024 23-May-2024 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve To take on record the Audited Financial Results of the Company (Standalone and Consolidated) for the quarter and Financial Year ended on 31st March 2024 as required under Regulation 33 of the SEBI Listing Regulations. 1. Considered, approved and took on record the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended on 31st March, 2024. 2. Considered and approved the re-appointment of Mr. Vikram Mehra (DIN: 03556680) as Managing Director of the Company for a period of 5 years, subject to the approval of Members of the Company Considered and approved Audited Financial Results for the quarter and financial year ended 31st March, 2024 Considered and approved re-appointment of Mr. Vikram Mehra as Managing Director of the Company for a period of 5 years (As per BSE Announcement Dated on 23/05/2024)
02-Feb-2024 09-Feb-2024 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve To consider approve and take on record the Unaudited Financial Results of the Company (Standalone and Consolidated) for the quarter and nine months ended on 31st December 2023 and may consider and approve a proposal for declaration of Interim Dividend for the Financial Year 2023-24 and fixing the Record Date for the said purpose. Approved and declared interim dividend of Rs. 4 per equity share (As per BSE Announcement Dated on 09/02/2024)
26-Oct-2023 01-Nov-2023 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve Unaudited Financial Results of the Company (Standalone and Consolidated) for the quarter and half year ended on 30th September 2023 Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations the Board of Directors of the Company at its meeting held today, i.e., Wednesday, 1st November, 2023, has inter-alia considered, approved and taken note of the Unaudited Financial Results (Standalone and Consolidated) of the Company, for the quarter and half year ended 30th September, 2023. Unaudited Financial Results (Standalone and Consolidated) of the Company, for the quarter and half year ended 30th September, 2023 Considered and approved appointment of Ms. Kusum Dadoo (DIN 06967827) as an Additional Director (in the category of Non-Executive Independent Director) with effect from 1st November, 2023 Took note of the resignation of Ms. Suhana Murshed (DIN 08572394) from the position of Non-Executive Independent Woman Director with effect from 2nd November, 2023 due to personal reasons. (As Per BSE Announcement Dated on 01/11/2023)
19-Jul-2023 27-Jul-2023 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve a. the Revised Audited Financial Results of the Company (Standalone and Consolidated) for the quarter and Financial Year ended 31st March 2023; and b. the Unaudited Financial Results of the Company (Standalone and Consolidated) for the quarter ended 30th June 2023 Saregama India Limited has informed the Exchange regarding the Board Meeting held on 27th July, 2023 to consider and approve the Revised Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2023. The Board meeting commenced at 10:30 a.m. and subsequent to the approval of the above matters, will continue till its scheduled time up to 01:00 p.m. Saregama India Limited has informed the Exchange regarding the Board Meeting held on 27th July, 2023 to consider and approve the Revised Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2023. The Board meeting commenced at 10.30 a.m, and subsequent to the approval of above matters, will continue till its scheduled time upto 01.00 p.m. Saregama India Limited has informed the Exchange regarding the Board Meeting held on 27th July, 2023 to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2023 and regarding the amendment to ''Employee Stock Option Scheme - 2013'', subject to approval of the members of the Company. (As Per BSE Announcement Dated on 27.07.2023)
12-May-2023 19-May-2023 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2023 inter alia to consider and approve the Audited Financial Results of the Company (Standalone and Consolidated) for the quarter and Financial Year ended 31st March 2023 as required under Regulation 33 of the SEBI Listing Regulations We write to inform you that pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), the Board of Directors of the Company ('the Board'), at its Meeting held today, i.e., Friday, 19th May, 2023, has considered and approved the Audited Financial Results (Standalone and Consolidated) of the Company, for the Quarter and Financial Year ended 31st March, 2023. A copy of the said results, along with the Statement of Assets and Liabilities, Auditors'' Report and declaration on Audit Reports with an unmodified opinion are enclosed herewith for your record. (As Per BSE Announcement Dated on 19.05.2023)
12-Jan-2023 20-Jan-2023 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended (referred to as the SEBI Listing Regulations) we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday 20th January 2023 inter-alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended 31st December 2022 along with the Limited Review Report as required under Regulation 33 of the SEBI Listing Regulations. In continuation to our Board meeting intimation dated 12th January, 2023 and pursuant to Regulation 29 and 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (referred to as the 'SEBI Listing Regulations'), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 20th January, 2023, inter-alia, to consider and approve a proposal for declaration of Interim Dividend for the Financial Year 2022-23 and for fixing the Record Date for the said purpose. (As Per BSE Announcement dated on 17.01.2023) We write to inform you that pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (hereinafter referred to as the 'SEBI Listing Regulations'), the Board of Directors of the Company ('the Board'), at its Meeting held today, i.e., Friday, 20th January, 2023, has: 1. Considered, approved, and took on record the Unaudited Financial Results (Standalone and Consolidated) of the Company, for the quarter and nine months ended on 31st December, 2022 of the Financial Year 2022-23. 2. Pursuant to Regulation 42 of the SEBI Listing Regulations, the Board have approved and declared an interim dividend of Rs.3/- per equity share (i.e. 300% on the face value of Re.1/- each) on the paid-up equity share capital of the Company (As Per BSE Announcement Dated on 20.01.2023)
21-Oct-2022 31-Oct-2022 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2022 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended (referred to as the SEBI Listing Regulations) we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday 31st October 2022 inter-alia to consider and approve the Unaudited Financial Results of the Company of the 2nd quarter and half year ended on 30th September 2022 as required under Regulation 33 of the SEBI Listing Regulations. 1. Considered, approved, and took on record the Unaudited Financial Results (Standalone and Consolidated) of the Company, for the quarter and half year ended on 30th September, 2022 of the Financial Year 2022-23. 2. Approved the appointment of M/s Link Intime India Private Limited (SEBI Registration No. INR000004058) as the Registrar and Share Transfer Agent ('RTA') of the Company in place of M/s MCS Share Transfer Agent Limited (SEBI Registration No. INR000004108). Approved the appointment of M/s Link Intime India Private Limited (SEBI Registration No. INR000004058) as the Registrar and Share Transfer Agent ('RTA') of the Company in place of M/s MCS Share Transfer Agent Limited (SEBI Registration No. INR000004108). We write to inform you that pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company (the 'Board'), at its Meeting held today, i.e., 31st October, 2022 inter-alia, has: 1. Considered, approved, and took on record the Unaudited Financial Results (Standalone and Consolidated) of the (As Per BSE Announcement Dated on 31.10.2022)
13-Aug-2022 13-Aug-2022 Submission of information pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Intimation of Grant of Stock Options under Saregama Employee Stock Option Scheme 2013
25-Jul-2022 02-Aug-2022 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2022 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 2nd August 2022 inter-alia to consider and approve the Unaudited Financial Results of the Company (Standalone and Consolidated) for the quarter ended 30th June 2022 as required under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended. Unaudited Financial Results (Standalone and Consolidated) of the Company, for the quarter ended 30th June, 2022 along with the Limited Review Report given by the Statutory Auditor of the company viz. M/s. B S R and Co. LLP, Chartered Accountants. A copy of the same are enclosed. Further pursuant to the provisions of SEBI Listing Regulations, please find enclosed the following: i. Earnings Release ii. Investor Presentation 2.Appointment of Ms. Priyanka Motwani (Membership No. ACS 58041) as the Company Secretary and Compliance Officer of the Company with immediate effect. She will be responsible for ensuring compliances under Companies Act, 2013, SEBI Listing Regulations and SEBI (Prohibition of Insider Trading) Regulations, 2015 (the 'SEBI PIT Regulations'). In terms of Regulation 30(5) of SEBI Listing Regulations, Updation of Contact details of Key Managerial Personnel(s) of authorized to determine the materiality of an Event or Information (As Per BSE Announcement Dated on 02.08.2022)
23-Apr-2022 02-May-2022 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2022 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (referred to as the 'SEBI Listing Regulations') as amended we write to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday 2nd May 2022 inter-alia to consider and approve the Audited Financial Results of the Company (Standalone and Consolidated) for the quarter and Financial Year ended 31st March 2022 as required under Regulation 33 of the SEBI Listing Regulations. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the 'SEBI Listing Regulations') and in terms of the Uniform Listing Agreement entered by the Company with your exchange, we would like to inform you that the Board of Directors of the Company (the 'Board'), at its Meeting held today, i.e. 2nd May, 2022, has inter-alia, considered and approved the following (As Per BSE Announcement dated on 02.05.2022)
05-Apr-2022 06-Apr-2022 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/04/2022 inter alia to consider and approve Fixation of record date in connection with Sub-division (split) of 1 (one) Equity Share of the Company having a face value of Rs. 10/- each (fully paid-up) to be sub-divided into 10 (Ten) Equity Shares of face value of Re. 1/- each (fully paid-up). Outcome of the Board Meeting held on April 6, 2022 (As Per BSE Announcement Dated 06.04.2022)
08-Feb-2022 24-Feb-2022 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/02/2022 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday February 24 2022 inter-alia to - (a) consider a proposal for sub-division of the Equity shares of the Company having a face value of Rs. 10/- each in such manner as may be determined by the Board of Directors; and (b) alteration of authorised share capital clause of the Company; subject to such regulatory/statutory approvals as may be required including the approval of the shareholders of the Company. The Board of Directors of the Company, at its Meeting held today, i.e. 24th February 2022, has inter alia, considered and unanimously approved the following: - 1. The adoption of new Articles of Association of the Company to make them consistent and aligned with the provisions of the Companies Act, 2013, as amended and the Rules framed thereunder and the provisions of Secretarial Standard on Board and General Meetings; and 2. Sub-division (split) of 1 (one) Equity Share of the Company having a face value of Rs. 10/- each (fully paid-up) to be sub-divided into 10 (Ten) Equity Shares of face value of Re. 1/- each (fully paid-up); and consequently, alteration of Capital Clause of the Memorandum of Association of the Company resulting from the said sub-division; (As Per BSE Announcement Dated on 24.02.2022)
11-Jan-2022 19-Jan-2022 SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/01/2022 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday January 19 2022 inter-alia to consider approve and take on record Un-audited Financial Results of the Company for quarter and nine months ended December 31 2021 as required under Regulation 33 of the SEBI Listing Regulations. With reference to the earlier letter dated January 11, 2022 regarding Board Meetinig Intimation, Saregama India Ltd has now informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on January 19, 2022, inter-alia, to consider and approve a proposal for declaration of Interim Dividend for the Financial Year 2021-22 and for fixing the Record Date for the said purpose. In continuation to our Board meeting intimation dated January 11, 2022 and pursuant to Regulation 29 and 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, January 19, 2022, inter-alia, to consider and approve a proposal for declaration of Interim Dividend for the Financial Year 2021-22 and for fixing the Record Date for the said purpose. (As Per BSE Announcement Dated on 15.01.2022) Declared an interim dividend @INR 30/- per equity share (i.e. 300%) on the paid-up equity share capital of the Company payable to those members whose names appear in the Register of Members of the Company, or, will appear as beneficial owners (as per particulars furnished by the Depositories viz., National Securities Depository Limited and Central Depository Services (India) Limited) at the close of the business on February 1, 2022 being the Record date to ascertain the eligibility of members to receive the said interim dividend. This is to inform you that the Board of Directors of the Company at its meeting held today i.e. January 19, 2022 has: 1)Considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2021. 2)Appointed Mrs. Avarna Jain (DIN: 02106305), Non-Executive Director of the company, as the Vice Chairman of the Board. 3)Declared an interim dividend @INR 30/- per equity share (i.e. 300%) on the paid-up equity share capital of the Company payable to those members whose names appear in the Register of Members of the Company, or, will appear as beneficial owners (as per particulars furnished by the Depositories viz., National Securities Depository Limited and Central Depository Services (India) Limited) at the close of the business on February 1, 2022 being the Record date to ascertain the eligibility of members to receive the said interim dividend. This is to inform you that the Board of Directors of the Company at its meeting held today i.e. January 19, 2022 has: 1)Considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2021 (As Per BSE Announcement Dated on 19.01.2022)
02-Nov-2021 02-Nov-2021 Pursuant to the approval accorded by the board of directors of the Company (the 'Board'), at its meeting held on September 16, 2021, and the shareholders of the Company, pursuant to the special resolution passed in the extra-ordinary general meeting held through video conferencing ('VC') / other audio-visual means ('OAVM') facility on October 19, 2021, the Board held a meeting today i.e. November 2, 2021. We wish to inform you that the Board has, inter-alia, passed the following resolutions We wish to inform you that pursuant to the approval accorded by the board of directors of the Company (the 'Board'), at its meetings held on September 16, 2021 and November 2, 2021, and the shareholders of the Company, pursuant to the special resolution passed in the extra-ordinary general meeting held through video conferencing ('VC') / other audio-visual means ('OAVM') facility on October 19, 2021 ('EGM'), the Fund Raising Committee (the 'Committee') has, at its meeting held today i.e. November 2, 2021, inter alia, passed the following resolutions: a. Authorizing the opening of the Issue today, i.e. November 2, 2021; b. Approving the floor price for the Issue, being ? 4264.68 per Equity Share ('Floor Price'), based on the pricing formula as prescribed under the SEBI ICDR Regulations; and c.Approving and adopting the preliminary placement document dated November 2, 2021, together with the application form in connection with the Issue.
04-Oct-2021 11-Oct-2021 Quarterly Results SAREGAMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/10/2021 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, October 11, 2021, inter-alia, to consider, approve and take on record Un-audited Financial Results of the Company for quarter and half year ended September 30, 2021 as required under Regulation 33 of the SEBI Listing Regulations. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the 'SEBI Listing Regulations') and in terms of the Uniform Listing Agreement entered by the Company with your Exchange, we would like to inform you that a meeting of the Board of Directors of the Company (the 'Board') was held today i.e. October 11, 2021, wherein the Board has, inter-alia, considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2021. A copy of the Un-audited Financial Results for the quarter and half year ended September 30, 2021 along with the Limited Review Report received from the Statutory Auditors viz. M/s. BSR and Co. LLP, Chartered Accountants on the Standalone and Consolidated Financial Results is enclosed. (As Per BSE Announcement dated on 11.10.2021) This is with reference to the meeting of the board of directors ('Board') of the Company held on October 11, 2021, wherein the Board had, inter-alia, considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2021. In compliance with Regulation 30 and 33 of the SEBI Listing Regulations and in terms of the Uniform Listing Agreement entered by the Company with the stock exchanges, we had filed an outcome of the board meeting per the timeline provided in the SEBI Listing Regulations. Further, an investor presentation and a corporate presentation ('Presentation') was also submitted by the Company to the stock exchanges along with the outcome of the said Board meeting. We are hereby filing revised Presentation which also inter alia includes strategies for our business. We request you to note that there are no revisions to the financials numbers disclosed in the earlier Presentation (As per BSE Announcement Dated on 14/10/2021)
1 2 3  Next